At the Midwest Business Group on Health (MBGH)’s 39th annual conference, Cheryl Larson, president and chief executive officer of MBGH, and Denise Giambalvo, vice president of MBGH, discussed a range of topics affecting employers, including trust with employees, popular initiatives, the cost of specialty drugs, and various proposals and policies from the Trump administration, such as getting rid of drug rebates and including drug prices in TV ads.
As the cost of healthcare continues to rise, employers are getting more involved in their employees’ health and identifying ways they can intervene to help employees who have chronic conditions get healthy or get access to care they need and also keep employees who are already healthy from getting sick.
At the Midwest Business Group on Health (MBGH)’s 39th annual conference, Cheryl Larson, president and chief executive officer of MBGH, and Denise Giambalvo, vice president of MBGH, discussed a range of topics affecting employers, including trust with employees, popular initiatives, the cost of specialty drugs, and various proposals and policies from the Trump administration, such as getting rid of drug rebates and including drug prices in TV ads.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
Read coverage from the Midwest Business Group on Health’s annual conference.
Fendrick: Embrace of VBID Even More Crucial Amid Equity Conversations, Braidwood Ruling
May 24th 2023Kicking off the 2023 Greater Philadelphia Business Coalition on Health annual conference, Mark Fendrick, MD, of the University of Michigan, delivered a keynote exhorting the audience of employers and payers to implement the principles of value-based insurance design (VBID) in order to improve individual and population health and drive toward equity.
Read More